Fluxion Launches BioFlux One, the Affordable System for Cellular Interaction Assays Under Physiological Flow

Wednesday, March 18, 2020 General News
Email Print This Page Comment bookmark
Font : A-A+

All the benefits of the industry leading BioFlux cell analysis platform, now in a configuration every lab can afford.

ALAMEDA, Calif., March 18, 2020 /PRNewswire/ -- Fluxion Biosciences, the leading developer of live cell analysis systems that feature physiological shear flow, has just announced the release of BioFlux One, its most affordable BioFlux system.

The BioFlux One system is the solution for labs that run flow cell experiments but don't need 2-phase flow. It provides all the benefits of the industry standard BioFlux system, but at a price point similar to a "home brew" flow cell setup. The BioFlux system is the established standard for a wide range of cellular interaction assays under physiological flow. Now, the BioFlux One system delivers the capability to perform complex modeling of the in vivo cell environment, in a package that every lab can afford.

The heart of the BioFlux One system is identical to the BioFlux 200 and the BioFlux 1000z systems: automated control of flow cell experiments with Fluxion's unique microfluidic flow cell well plates. The BioFlux One can run up to 6 simultaneous flow cell experiments and is ideal for platelet aggregation, leukocyte adhesion, and biofilm analysis.

As with all BioFlux systems, the BioFlux One works with an inverted microscope and is compatible with fluorescence, bright field, phase, and confocal imaging. User-friendly software automates experimental protocols and provides a powerful analysis package. Upgrade capabilities allowing for 2-phase flow and/or higher throughput make the BioFlux One the perfect choice for your functional assay research.

"We're excited to democratize access to BioFlux technology. For labs needing an easy to use flow assay with low reagent consumption but don't run at high throughput, BioFlux One is the right solution," said Cristian Ionescu-Zanetti, Fluxion's Chief Technology Officer. "This will accelerate research efforts and enable the development of a new set of innovative assays."

The BioFlux One system is available immediately, with North American pricing for complete systems starting at less than $10,000 USD.

About Fluxion Biosciences

Fluxion Biosciences is a global leader in analytical, live cell analysis tools in a microfluidic format. BioFlux, Fluxion's cellular analysis system, provides the ability to emulate physiological shear flow in an in vitro model, while still maintaining a convenient well plate format. For more information about BioFlux systems, visit https://bioflux.fluxionbio.com/.

Media contact:Jeff Jensen236183@email4pr.com   650-241-4747

Cision View original content:http://www.prnewswire.com/news-releases/fluxion-launches-bioflux-one-the-affordable-system-for-cellular-interaction-assays-under-physiological-flow-301025946.html

SOURCE Fluxion Biosciences



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store